Sylvia Natividad-Diaz is a Bioengineering PhD candidate at the University of California, Berkeley and works a graduate student researcher in Professor Kevin Healy’s Biomaterials lab. She has a bachelor’s and master’s degree in Materials Engineering from the University of Texas at El Paso. Her dissertation project focuses on developing a minimally invasive therapy to help regenerate post-infarction ischemic myocardium by using vascular endothelial cells and cardiomyocytes derived from human induced pluripotent stem cells. These cells are co-cultured in a tunable, growth factor sequestering hyaluronic acid scaffold to promote cell survival and maintenance of lineage-specific function (i.e. angiogenesis, contraction/relaxation, paracrine signaling). By incorporating chemical signals that promote cell adhesion, proliferation, and angiogenesis, this stem cell-based therapy is expected to regenerate damaged cardiovascular tissue.